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Abstract. Obesity is a growing epidemic that has increased steadily over the 
past several decades. It affects significant parts of the global population and this 
has resulted in obesity being high on the political agenda in many countries. It 
represents one of the most difficult clinical and public health challenges 
worldwide. While eating healthy and exercising regularly are obvious ways to 
combat obesity, there is a need to understand the underlying genetic constructs 
and pathways that lead to the manifestation of obesity and their susceptibility 
metrics in specific individuals. In particular, the interpretation of genetic 
profiles will allow for the identification of Deoxyribonucleic Acid variations, 
known as Single Nucleotide Polymorphism, associated with traits directly 
linked to obesity and validated with Genome-Wide Association Studies. Using 
a robust data science methodology, this paper uses a subset of the TwinsUK 
dataset that contains genetic data from extremely obese individuals with a 
BMI≥40, to identify significant obesity traits for potential use in genetic 
screening for disease risk prediction. The approach posits a framework for 
methodical risk variant identification to support intervention strategies that will 
help mitigate long-term adverse health outcomes in people susceptible to 
obesity and overweight.  
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1. Introduction 
According to the World Health Organization (WHO) 1, the occurrence of obesity 
and overweight worldwide has doubled since 1980. More recently, the figures suggest 
that in 2014 more than 1.9 billion adults were overweight and 600 million were obese. 
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The condition was initially recognized as a disease in 1948 by the WHO [1] and since 
then its prevalence has continued to increase making it a global phenomenon and one 
of the main contributors to poor health. Today it is considered one of the most difficult 
clinical and public health challenges worldwide [2]–[4]. It is the leading cause of Type 
2 Diabetes, cardiovascular disease, premature death, hypertension, osteoarthritis, stroke 
and certain cancers [2],[3],[5]. Consequently, it is high on the political agenda of many 
countries. While North America is considered the most obese continent, the UK is 
ranked as one of the most obese nations in Europe2.   
The predisposition to obesity in humans is referred to as polygenic obesity and is 
considered a complex and multifactorial disease that manifests itself through 
interactions between genetic, behavioural and environmental factors. While obesity 
tends to exist within families, the way it is inherited does not correspond to known 
patterns. We know that it is dependent on environmental factors and numerous studies 
have shown that an individual’s predisposition to obesity is more similar among 
genetically related individuals than those that are not. The phenotypes associated with 
obesity exhibit significant additive heritability (the proportion of the variability of a 
trait that is attributable to genetic factors) [6]. In the particular case of Body Mass 
Index (BMI), family and twin studies have shown that between 40% and 70% of the 
inter-individual variation in susceptibility to obesity can be attributed to genetic 
differences in the population [7]–[9]. The remaining percentage is associated with 
other factors, such as lifestyle. It is clear that the prediction of obesity based solely on 
genetic information will never be completely accurate. Thus, the ideal genetic 
predictor, should complement, but never replace traditional predictors. 
Building on existing works and tools for genetic analysis, this paper explores 
polygenic obesity and associated risk factors. Using a robust data science 
methodology, data extracted from Genome-Wide Association Studies (GWAS) is 
utilised to identify significant Single Nucleotide Polymorphism’s (SNPs) associated 
with obesity traits. This study serves as a genetic analytics framework for the 
interpretation of genetic profiles for the discovery of significant biomarkers and their 
associated genes for use in early detection and intervention strategies.  
2. Background 
The central dogma of molecular biology describes how cells replicate their 
Deoxyribonucleic Acid (DNA) in daughter cells via cell division. It also focuses on 
how proteins are synthesized from DNA, according to the flows of information from 
DNA to ribonucleic Acid (RNA) and RNA to protein. Genes encode amino acid chains 
that compose the proteins, which have specific functions in the organism [10], [11]. 
Understanding the function of each gene, and the proteins they synthesize can help to 
identify the cause(s) of different diseases. This has the real potential to find better ways 
to treat and prevent diseases through early detection and prevention strategies, 
personalized drugs and tailored therapies.  
                                                 
2 http://www.who.int/ 
In the context of polygenic obesity, this disease is complex and does not exhibit a 
typical Mendelian pattern of transmission. There is evidence derived from GWAS that 
suggest single nucleotide polymorphisms (SNPs) in certain genes are associated with 
obesity risk factors and BMI. Examples of these genes include those associated with 
fat mass and obesity (FTO) and the Melanocortin 4 receptor gene (MC4R) [12]–[15]. 
Additional studies have reported that certain genes, including those mentioned, have a 
strong link with energy consumption in the nervous system when the hypothalamus 
part of the brain is stimulated [16]. 
While in [17], a meta-analysis of 340,000 people was conducted and 97 Genome-
wide Significance (GWS) loci associated with BMI were reported, of which 56 were 
novel. At least 52 of these have been previously identified and are reported to be 
associated with a predisposition to obesity. However, their predictive capability is 
poor, because it only explains a fraction of the total variance. Therefore, it cannot 
compete with the predictability of traditional risk factors such as, obesity in parents and 
children. Nonetheless, some of these loci are currently being used in direct-to-
consumer (DTC) personal genomic profiles to estimate the risk of obesity in the lives 
of individuals [15]. 
The predictive capability of loci is however likely to improve as the cost of genetic 
sequencing decreases. In 2003, the cost was $2.7 billion, while in 2013 it was $5000 
[18]. This has resulted in a plethora of sequencing methods designed to determine the 
order of nucleotide bases that make up a molecule of DNA or RNA [19]. The first 
generation of sequencing, known as Sanger sequencing, made the Human Genome 
Project possible. More recently, these have been replaced with next-generation 
sequencing (NGS) techniques that provide cheaper alternatives [20], [21]. In particular, 
they allow for faster discovery of genes and regulatory elements associated with 
diseases, thus significantly increasing the clinical diagnosis performed with the nucleic 
acid sequence. 
This is further supported by the fact that a considerable number of base pairs 
(nucleotides) in the human genome are identical for all humans [22]. Hence, in genetic 
association studies, bases where there is variation between humans are only 
considered. These differences are commonly referred to as SNPs. Initially, studies 
were commissioned to investigate the basic genetics of common obesity based on 
candidate gene approaches and linkage analyses. However, other types of more 
effective studies utilizing hypothesis-free methodologies have been used in obesity 
studies to identify many obesity related loci. These studies are termed GWAS and 
permit the analysis of a larger number of genetic variants for association with traits of 
interest.  
However, despite these advances, sequencing the whole genome is still expensive; 
therefore, researchers tend to focus on coding regions of the human genome known as 
exons. It is estimated that 85% of disease-causing mutations are located in coding and 
functional regions of the genome, so whole-exome sequencing (WES) methods are a 
potential alternative to unravel the cause of rare genetic disorders [23].  
This paper adopts this approach were 68 exonerated sequenced samples from 
extremely obese people are used and compared with a publicly available and manually 
curated collection of published GWASs.  
3. Methodology 
In this paper, we compare the genetic profiles of extremely obese people, obtained 
from the UK10K_OBESITY_TWINSUK REL-2013-04-20 dataset hosted by Sanger 
Institute3, with GWAS results indexed in the National Human Genome Research 
Institute (NHGRI) Catalog4. The dataset represents 68 cases of extremely obese twins. 
These samples are a subset of the TwinsUK cohort samples that have a BMI≥40 and 
were exome sequenced by the UK10K Obesity group [24], [25].  
The UK10K_OBESITY_TWINSUK REL-2013-04-20 dataset contains SNPs and 
associated metadata variables that include chromosome, position, disease trait and 
strongest risk allele. The samples in the VCF format were sequenced using GRCh37 
and accessed in NHGRI Catalog data (hg19 genome build) based on this assembly.  
The primary focus in this study is to identify the frequency of SNPs or their 
variants of interest in the 68 examined profiles (only Europeans considered) and which 
of these are indexed in the NHGRI Catalog. This mapping allows us to link SNP-traits 
in our samples with risk alleles indexed in the NHGRI Catalog. This process results in 
a set of traits that best represent phenotypes related to obesity.  
3.1 Data Pre-Processing 
The dataset contains 5,827,333 observations (records) and 4 variables that describe 
the chromosome number, position, SNP ID and REF, and ALT bases which are 
combined to represent the genotype, as shown in in Table 1. These are the variables 
used in this study to identify SNPs and risk alleles previously reported in GWAS and 
indexed in the NHGRI Catalog. Column names were edited for simplicity and 
convenience. 
#Chrom Position RSID Genotype 
1 14907 Rs79585140 A/G 
1 63671 Rs116440577 G/A 
1 63697 Rs201582574 T/C 
1 69511 Rs75062661 A/G 
Table 1: Columns extracted from the UKTwins dataset and used in this study 
In the initial data pre-processing stages observations with missing values (NA 
values) were removed including those observations with no SNP IDs. Duplicate SNPs 
in all the samples were summed and utilised as a feature to represent SNP frequency. 
This initial data pre-processing step reduced the number of observations from 
5,827,333 to 361,899. 
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3.2 NHGRI Catalog comparison 
Using metadata from the NHGRI Catalog (“ebicat37”) the SNP ID and the 
Genotype contained in the samples were linked with SNPs and risk alleles reported in 
the Catalog. This was achieved by using the RSID and Genotype values in the samples 
to index SNPS and STRONGEST.SNP.RISK.ALLELE in the NHGRI Catalog. Those 
SNPs with risk alleles marked as “?” in the Catalog where discarded from our samples. 
This resulted in 1,304 matching SNPs from our samples. However, the potential 
risk alleles identified in the NHGRI Catalog were obtained in studies conducted using 
people from different populations and ethnic backgrounds. Therefore, since our 
samples belonged to UK twins, only those variants identified in studies conducted in 
European populations were used. This was achieved using a filtering process to select 
SNPs where the column INITIAL.SAMPLE.DESCRIPTION contained the word 
“European”. This reduced the number of SNPs further to 1,041 – 11 variables were 













Table 2: Variables selected after European filtering process. 
Following the identification of risk variants associated with European populations, 
traits linked with obesity were selected as shown in Table 3. 
Variables Abbreviations 
Body mass index BMI 
Visceral adipose tissue adjusted for BMI VATaBMI 
Obesity O 
Obesity(early onset extreme) OEOE 
Weight W 
Weight loss WL 
Birth weight BW 
Height H 
Fat body mass FBM 
Eating disorders ED 
Waist-hip ratio WHR 
Waist Circumference WC 
Table 3: Obesity traits selected. 
Figure 1 shows the 1041 SNPs contained in our dataset that are indexed in the 
NHGRI Catalog. The x axis represents the chromosomes, while the y value shows each 
of the SNPs – the strongest associations have the smallest P-values, therefore negative 
logarithms will be the greatest. So while all of the SNPs in the study are considered to 
be statistically significant, SNPs with higher y values are deemed to be the most 
significant. The SNPs highlighted in green correspond to the obesity-related traits 
previously listed in Table 3. The –log10(p) represents the statistical significance of the 
association reported in the GWAS. 
 
Figure 1: Manhattan plot with obesity traits highlighted in green. 
SNPs where identified in chromosomes 1, 2, 3, 4, 5, 6, 9, 10, 11, 12, 15, 16, 17, 19, 
20 and 22. However, the chromosomes of specific interest are 1, 3 and 19 which each 
have four obesity SNPs. It should be noted that not all the SNPs included in the three 
chromosomes are significant as will be discussed in more detail in the results section.  
Using our 1041 SNPs, we filtered the dataset to only include those SNPs related to 
obesity – this reduced the dataset to 39 obesity related SNPs. Figure 2 describes the 39 
obesity related SNPs that appear in the initial 68 samples of extremely obese subjects. 
 Figure 2: Obesity related traits and their frequency in different chromosomes  
Figure 2 represents the SNPs and their obesity associated traits for each 
chromosome – colours show the frequency of the variants. The full trait names 
described on the y axis are listed in Table 3. The SNPs that are repeated more than 45 
times are labelled in Figure 2. In some cases, SNPs overlap as they are related to the 
same traits in the same chromosome. The trait height was identified nineteen times in 
different chromosomes. Obesity was also found in 5 chromosomes. The trait obesity 
(early onset extreme). Waist-hip ratio and obesity (early onset extreme) traits are 
represented in pink and labelled as they were repeated 68 and 64 times respectively.  
Surprisingly, one of the SNPs associated with body mass index, rs13107325 
(chromosome 4), was only repeated in six samples and for that reason it was 
represented as an orange-green colour. 
4. Results 
In this study we investigated the occurrence of SNPs in 68 samples of cases with 
extreme obesity. The results in Table 4 provide a brief description of the obesity 
related SNPs that were identified in the samples. The table identifies the chromosome 
number, position, SNP id, SNP frequency, obesity trait, p-value and reported genes. 
From all the traits identified, the most prominent, given its association with 19 
identified SNPs, is height. However, this trait would not represent a risk as in most 
cases it corresponded to the REF base on the genotype, not the ALT. Nonetheless, we 
do not have any clinical data to confirm this. 
#Chrom Position SNP ID Freq Trait P.Value Reported 
Genes 
1 149906413 rs11205303 42 Height 4e-23 MTMR11 
1 150727539 rs2230061 40 Fat body mass 4e-08 CTSS 
1 184023529 rs1046934 39 Height 2e-31 TSEN15 
1 3649562 rs9662633 5 Visceral adipose tissue 
adjusted for BMI 
6e-06 TP73 
2 232378231 rs6750795 57 Height 2e-08 C2orf52 




3 52506426 rs6784615 68 Waist-hip ratio 4e-10 NISCH, 
STAB1 
3 56667682 rs9835332 49 Height 5e-13 C3orf63 
3 172165727 rs572169 41 Height 3e-18 GHSR 
3 172165727 rs572169 41 Height 1e-12 GHSR 
4 1701317 rs2247341 42 Height 2e-11 SLBP/FGF
R3 
4 103188709 rs13107325 6 Body mass index 2e-13 SLC39A8 
5 176517326 rs422421 62 Height 1e-12 FGFR4/NS
D1 
5 75003678 rs2307111 41 Obesity 3e-12 C5orf37 
5 159820931 rs10515808 12 Weight loss (gastric 
bypass surgery) 
4e-07 C1QTNF2 
6 32050067 rs185819 49 Height 3e-08 HLA class 
III 
9 95887320 rs2275848 64 Obesity (early onset 
extreme) 
1e-06 NINJ1 








10 115805056 rs1801253 62 Birth weight 4e-09 ADRB1 
11 8662516 rs11042023 62 Obesity 1e-11 RPL27A 
12 124399550 rs1316952 18 Visceral adipose tissue 
adjusted for BMI 
5e-06 DNAH10 
12 56740682 rs2066807 5 Height 1e-13 STAT2 
15 74336633 rs5742915 45 Height 1e-15 PML 
15 89388905 rs16942341 4 Height 4e-27 ACAN 
16 28883241 rs7498665 39 Obesity 3e-13 SH2B1 
16 28883241 rs7498665 39 Body mass index 5e-11 SH2B1 
16 28883241 rs7498665 39 Body mass index 3e-10 ATP2A1, 
SH2B1 
16 28883241 rs7498665 39 Obesity 5e-12 SH2B1 
16 28883241 rs7498665 39 Weight 1e-09 ATP2A1, 
SH2B1 
17 43216281 rs4986172 33 Height 2e-16 ACBD4 
17 47390014 rs2072153 29 Height 4e-08 ZNF652 
19 41937095 rs17318596 36 Height 5e-16 ATP5SL 
19 46202172 rs2287019 27 Body mass index 2e-16 GIPR, 
QPCTL 
19 46181392 rs1800437 25 Obesity 3e-14 GIPR 
19 17283303 rs2279008 25 Height 3e-08 MYO9B 
20 34025756 rs143384 39 Height 1e-58 GDF5 
20 32333181 rs7274811 26 Height 6e-22 ZNF341 
22 42336172 rs5758511 30 Birth weight 3e-06 CENPM 
22 40820151 rs5757949 29 Height 4e-06 MKL1, 
SGSM3 
Table 4: Obesity related SNPs identified in the 68 extremely obese samples. 
Our findings show that the SNP associated with the waist-hip ratio trait, rs6784615, 
was present across all samples, followed by the SNP rs2275848, associated with 
obesity (early onset extreme) which is repeated 64 times. Other outstanding SNPs such 
as rs1801253, rs11042023 and rs514024 were linked to birth weight, obesity and 
eating disorders and were present in 61, 61 and 56 of the samples respectively. 
The SNP rs7498665 in chromosome 16 has been associated to several obesity-
related traits according to the information included in the NHGRI Catalog. This 
particular SNP has been identified in 36 of our samples and can be related to body 
mass index, obesity or weight traits. It has also been associated with other genes, such 
as SH2B1 and ATP2A1. 
Although this study has focused of risk variants associated with obesity traits, other 
SNPs with other traits within the 10 most repeated have also been identified. In 
addition to rs6784615, the SNP rs37370 was also present in all samples which is 
linked to Asymmetrical dimethylarginine levels. Other SNPs were associated with 
psoriasis, parkinson's disease, osteosarcoma, Insulin-like growth factors, coronary 
heart disease, myocardial infarction (early onset), inflammatory bowel disease, 
Ulcerative colitis, blood metabolite levels, Type 2 diabetes as well as some type of 
cancer among other diseases. In future works these SNPs and their association with 
obesity, including causation factors will be studied further.   
5. Discussion 
Understanding obesity as a complex disease is an arduous task. In an attempt to 
better understand how obesity is developed, we sought to identify the main genetic 
variants present in samples of people with extreme obesity. This was achieved using 
information contained in the NHGRI Catalog as a reference for the identification of 
risk variants in our samples. The methodology proposed in this paper investigated a 
solid foundation for identifying SNPs and their associated risks and in this sense 
provides a foundation for much more complex genetic analytics.  
However, the study has a number of limitations, the major one being the size of the 
dataset – 68 samples are not representative of a population. However, we did analyse 
samples belonging to twins in the UK which is part of a more limited and specific 
population group.  
The lack of contextual information about the samples also proved to be an issue. 
Although we knew that the samples belonged to British twins with extreme obesity 
(BMI> 40), we did not have any other information regarding their age, gender, lifestyle 
or clinical history, which greatly limited the scope of this study. For this reason, using 
manipulation and data visualization techniques, the objective of this study was to 
identify statistically significant obesity related variants from GWAS. This has provided 
a robust foundation for future research directions, particularly in the area of detection 
and prediction and the use of advanced machine learning algorithms, which will be the 
focus of our future work. 
We also compared whole-exome sequencing data (WES data) against whole 
genome results data (GWAS data) and this means that we could be ignoring other 
regions of the DNA that could provide more insights to our study which will be 
considered in future work.   
Starting from an initial number of 5827333 observations, we managed to reduce the 
dataset using standard data science tools and techniques, such as R5 and Bioconductor6 
allowing us to identify 39 SNPs associated with obesity risks listed in Table 4. Among 
all the SNPs associated with obesity the most prominent one in the 68 samples was 
rs6784615. This SNP is associated with waist-hip ratio (WHR), a trait commonly used 
when it comes to quantifying obesity [15]. 
6. Conclusions 
The identification of biomarkers contained in the entire genome, or more 
specifically, those found in the protein-coding regions or exons, has helped us to 
identify genetic variations associated with particular traits in extremely obese samples.  
This study used a manually curated and publicly available dataset with results from 
GWAS for the identification of obesity-related traits in 68 extremely obese samples. 
Metadata from the NHGRI Catalog was accessed using the R/Bioconductor package 
gwascat and the hg19 genome build ebicat37. The dataset and the samples were 
analysed using rigorous data science techniques, which led to a significant reduction in 
the initial number of observations and the identification of SNPs that could help to 
explain the development of extreme obesity. Missing values and no relational data 
items were removed from the study. The variables rsid and genotype as well as SNPS 
and STRONGEST.SNP.RISK.ALLELE were the key for the identification of SNP-
obesity related traits in our samples. 
While the results show specific variants related to obesity traits present in all the 
samples, they are unlikely by themselves to be causative variants. The potential for 
variants identified in GWAS to predict the risk of complex diseases is problematic. At 
the moment, currently known variants do not fully explain the risk of disease 
occurrence to be of clinical use in predictive systems. However, the presence of 
specific obesity-related SNPs in extremely obese individuals could help us to gain a 
better understanding about what SNPs we need to look for. Of course, we need to 
consider the inclusion of contextual and clinical data and study the interaction between 
SNPs to gain a better understanding of obesity aetiology. The results do however raise 
further questions. First, it would be useful to see if the identified SNPs interact 
conjointly to cause extreme obesity. Second, it would also be useful to explore 
machine learning methods, such as support vector machines and other advanced 
artificial neural network architectures to study the non-linearity interaction between 
                                                 
5 https://www.r-project.org 
6 https://www.bioconductor.org/ 
SNPs. While this study focused on UK twins, it would be interesting to look at other 
population groups as well. 
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